tradingkey.logo
マヌケット
ニュヌス
分析
ツヌル
株匏スコア
株匏スコア



English
繁䜓䞭文
à¹„àž—àž¢
Tiếng việt
简䜓䞭文
Español
Português
Deutsch
한국얎
日本語

tradingkey.logo



AtriCure Inc

ATRC
28.880USD
-1.160-3.86%
終倀 03/27, 16:00ET15分遅れの株䟡
476.09M時䟡総額
損倱額盎近12ヶ月PER


AtriCure Inc

28.880
-1.160-3.86%
抂芁金融分析䌁業名

抂芁

金融

分析

䌁業名

詳现情報 AtriCure Inc 䌁業名

AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.

AtriCure Incの䌁業情報


䌁業コヌドATRC
䌚瀟名AtriCure Inc
䞊堎日Aug 05, 2005
最高経営責任者「CEO」Carrel (Michael H)
埓業員数1300
蚌刞皮類Ordinary Share
決算期末Aug 05
本瀟所圚地7555 Innovation Way
郜垂MASON
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号45040
電話番号15137554100
りェブサむトhttps://www.atricure.com
䌁業コヌドATRC
䞊堎日Aug 05, 2005
最高経営責任者「CEO」Carrel (Michael H)

AtriCure Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
790.06K
+11.53%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
158.05K
+20.54%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
106.40K
+25.94%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
102.17K
+9.79%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
96.88K
+25.81%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
96.05K
+28.63%
Mr. Sven A. Wehrwein, CPA
Mr. Sven A. Wehrwein, CPA
Independent Director
Independent Director
34.37K
--
Ms. Regina E. (Reggie) Groves
Ms. Regina E. (Reggie) Groves
Independent Director
Independent Director
33.72K
-7.27%
Ms. Deborah H. (Deb) Telman
Ms. Deborah H. (Deb) Telman
Independent Director
Independent Director
22.18K
+24.35%
Mr. Shlomo Nachman
Mr. Shlomo Nachman
Independent Director
Independent Director
18.51K
+29.18%
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
790.06K
+11.53%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
158.05K
+20.54%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
106.40K
+25.94%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
102.17K
+9.79%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
96.88K
+25.81%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
96.05K
+28.63%

収益内蚳

通貚: USD曎新時刻: Tue, Jan 6
通貚: USD曎新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
䌚瀟名
収益
比率
Appendage Management-United states
45.45M
33.85%
Open Ablation - United states
35.59M
26.51%
Pain management
20.84M
83.47%
Open ablation -International
10.85M
43.47%
Appendage management -International
10.17M
40.73%
他の
-97.94M
-128.04%
地域別USD
䌚瀟名
収益
比率
United States
109.31M
81.41%
Europe
15.17M
60.77%
Asia
8.08M
32.38%
Other international
1.71M
6.85%
事業別
地域別
事業別USD
䌚瀟名
収益
比率
Appendage Management-United states
45.45M
33.85%
Open Ablation - United states
35.59M
26.51%
Pain management
20.84M
83.47%
Open ablation -International
10.85M
43.47%
Appendage management -International
10.17M
40.73%
他の
-97.94M
-128.04%

株䞻

曎新時刻: Sat, Feb 21
曎新時刻: Sat, Feb 21
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
The Vanguard Group, Inc.
9.82%
Wellington Management Company, LLP
7.87%
AllianceBernstein L.P.
7.15%
BlackRock Institutional Trust Company, N.A.
6.96%
Hood River Capital Management LLC
6.22%
他の
61.98%
株䞻統蚈
株䞻統蚈
比率
The Vanguard Group, Inc.
9.82%
Wellington Management Company, LLP
7.87%
AllianceBernstein L.P.
7.15%
BlackRock Institutional Trust Company, N.A.
6.96%
Hood River Capital Management LLC
6.22%
他の
61.98%
皮類
株䞻統蚈
比率
Investment Advisor
50.02%
Investment Advisor/Hedge Fund
39.98%
Hedge Fund
7.59%
Individual Investor
4.06%
Research Firm
1.68%
Pension Fund
0.64%
Bank and Trust
0.61%
Sovereign Wealth Fund
0.43%
Family Office
0.07%

機関投資家保有株


曎新時刻: Mon, Dec 8
曎新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
492
49.59M
116.79%
-102.71K
2025Q3
520
49.71M
119.25%
-705.98K
2025Q2
524
50.25M
121.23%
-1.55M
2025Q1
527
51.69M
113.33%
-4.41M
2024Q4
514
47.94M
122.38%
-3.05M
2024Q3
505
52.36M
125.18%
-207.95K
2024Q2
494
52.59M
116.92%
+1.07M
2024Q1
500
51.55M
109.93%
-1.63M
2023Q4
498
48.92M
106.78%
+1.54M
2023Q3
486
47.46M
108.31%
+99.25K
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
The Vanguard Group, Inc.
4.83M
9.71%
-65.32K
-1.33%
Sep 30, 2025
Wellington Management Company, LLP
4.29M
8.63%
+322.82K
+8.13%
Sep 30, 2025
AllianceBernstein L.P.
3.56M
7.16%
-15.06K
-0.42%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
3.41M
6.86%
-34.35K
-1.00%
Sep 30, 2025
Hood River Capital Management LLC
3.05M
6.13%
-15.47K
-0.51%
Sep 30, 2025
Nomura Investment Management Business Trust
2.29M
4.6%
-213.84K
-8.54%
Sep 30, 2025
State Street Investment Management (US)
1.26M
2.54%
-9.44K
-0.74%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.19M
2.4%
+9.32K
+0.79%
Sep 30, 2025
First Light Asset Management, LLC
890.36K
1.79%
-124.81K
-12.29%
Sep 30, 2025
Champlain Investment Partners, LLC
1.98M
3.98%
-38.54K
-1.91%
Sep 30, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
State Street SPDR S&P Health Care Equipment ETF
1.75%
Harbor Human Capital Factor US Small Cap ETF
0.7%
Invesco NASDAQ Future Gen 200 ETF
0.5%
First Trust Small Cap Growth AlphaDEX Fund
0.44%
Fidelity Enhanced Small Cap ETF
0.33%
Amplify Etho Climate Leadership U.S. ETF
0.3%
Franklin US Small Cap Multifactor Index ETF
0.25%
JPMorgan Fundamental Data Science Small Core ETF
0.24%
iShares U.S. Medical Devices ETF
0.2%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.17%
詳现を芋る
State Street SPDR S&P Health Care Equipment ETF
比率1.75%
Harbor Human Capital Factor US Small Cap ETF
比率0.7%
Invesco NASDAQ Future Gen 200 ETF
比率0.5%
First Trust Small Cap Growth AlphaDEX Fund
比率0.44%
Fidelity Enhanced Small Cap ETF
比率0.33%
Amplify Etho Climate Leadership U.S. ETF
比率0.3%
Franklin US Small Cap Multifactor Index ETF
比率0.25%
JPMorgan Fundamental Data Science Small Core ETF
比率0.24%
iShares U.S. Medical Devices ETF
比率0.2%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
比率0.17%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™